Dose-Response Effects of Pecan Consumption on Blood Lipid Profiles in Adults with Excess Body Weight and/or Dyslipidemia: a Randomized Controlled Trial

Pecan intake providing 20% and 13%, but not 6%, of daily energy improved fasting blood lipid profiles compared with the control, with postprandial NEFA reductions observed only at 13%. These findings offer the first evidence that moderate doses of daily pecan consumption confer cardioprotective benefits. This trial was registered at clinicaltrials.gov as NCT05949879 and available from: https://clinicaltrials.gov/study/NCT05949879. The date of initial trial registration was 18 July, 2023.